Among the regulatory niche of immune cells, Cai, Shi, et al. (16) have elegantly demonstrated that CD8+ TRLs confer neuroprotection, although multiple interesting questions remain: (a) What environmental cues in the periphery or in the injured brain lead to the infiltration of CD8+ TRLs in the early phase of stroke? This evidence concerns the gene CD8A and stroke disorder.